Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PPA Still Available In U.K., Under Review In Canada

This article was originally published in The Tan Sheet

Executive Summary

Federal regulatory agencies in Canada and the U.K. have not followed FDA's lead in asking manufacturers to voluntarily halt distribution of all OTC products containing phenylpropanolamine.

You may also be interested in...



"PPA-Free" Ads Spring Up In Wake Of FDA Consumer Warning

FDA's consumer advisory on phenylpropanolamine has spawned a plethora of ads and public relations campaigns by companies highlighting the safety of their "PPA-free" remedies as the cold and flu season gets underway.

"PPA-Free" Ads Spring Up In Wake Of FDA Consumer Warning

FDA's consumer advisory on phenylpropanolamine has spawned a plethora of ads and public relations campaigns by companies highlighting the safety of their "PPA-free" remedies as the cold and flu season gets underway.

"PPA-Free" Ads Spring Up In Wake Of FDA Consumer Warning

FDA's consumer advisory on phenylpropanolamine has spawned a plethora of ads and public relations campaigns by companies highlighting the safety of their "PPA-free" remedies as the cold and flu season gets underway.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091915

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel